Introducing New HIV Prevention Products: The Dapivirine Ring and Injectable Cabotegravir for PrEP
TNIMH is conducting a webinar on new HIV Pre-Exposure Prophylaxis (PrEP) product introduction planning in Africa, including an overview of the CATALYST implementation study exploring PrEP choice that is being conducted through Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC).
Related Posts
Center for Global Mental Health Research Webinar Series: Submission and Peer Review of NIH Grant Applications
May 31, 2022
Nick Gaiano, Ph.D., focused on how to prepare and submit grant applications to...
Director’s Innovation Speaker Series: Implementing Radical Healing Strategies to Promote Health Equity
May 25, 2022
Helen A. Neville, Ph.D., will provide an overview of the psychology of the...
Center for Global Mental Health Research Webinar Series: Training Mechanisms for Graduate Students and Post-docs in Global Mental Health Research at NIH
July 8, 2022
This webinar discussed funding opportunities from NIH for graduate students and...
Study Shows REACH VET Program Effective for Veterans at High Risk for Suicide
May 25, 2022
A recent NIMH co-authored study shows that a Department of Veterans Affairs...